Redirect Notice
 The previous page is sending you to http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/9309426/AstraZeneca-bids-4bn-for-diabetes-specialist-Amylin.html.

 If you do not want to visit that page, you can return to the previous page.